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QUESTIONS
1. What are the major findings of the study?
2. Why is UV-induced immunosuppression important to cancer development?
3. Were the UV doses given in this study appropriate?
4. Is nicotinamide a sunscreen?
5. By what proposed mechanisms does nicotinamide work?
6. Were the gender differences observed in this study believable?
7. What may be the clinical implications of this article?
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UV light is a major risk factor for skin cancer development (Essen and 
Klar, 2006). The mechanisms by which UV leads to cancer formation 
are complex and appear not to be limited solely to UV-induced DNA 
damage. UV induces immune suppression, which is associated with 
increased skin cancer formation, as evidenced by the increased cancer 
risk in immunosuppressed transplant patients (Bergstresser, 1983; Ulrich 
and Stockfleth, 2007). Therefore, protection against UV-induced immune 
suppression may have clinical benefits.
In this issue, Damian et al. (2008) explore the potential role of topical 
nicotinamide in preventing UV immunosuppression in humans, 
based on animal models to prevent UV-induced immune suppression. 
Using volunteers with a positive Mantoux test (purified protein derivative positive from Bacille Calmette-Guérin 
vaccination), the authors studied the ability of topical nicotinamide to prevent UVB immune suppression and the 
mechanisms by which this occurred. They found that when nicotinamide was applied either before or after UV 
exposure (simulating normal sunlight exposure), the typically encountered immune suppression was reduced. 
Additionally, men were more sensitive to UV-light-induced immune suppression, which the investigators 
concluded may account, in part, for the greater incidence of skin cancer and skin cancer mortality in men. 
Nicotinamide did not work as a sunscreen but rather, as suggested by microarray analysis, as a mechanism that 
may include alterations in complement, energy metabolism, and apoptosis.
Through the following questions we will delve into this paper in greater detail. For brief answers, please refer to 
http://network.nature.com/group/jidclub.
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